Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
| Status: | Completed |
|---|---|
| Conditions: | Parkinsons Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2014 |
| End Date: | December 2014 |
Kinesia-D Phase II In-Clinic Continuous Assessment Study
The objective is to assess a compact, portable, wireless movement disorder system with
continuous monitoring capabilities to detect and quantify the severity of levodopa-induced
dyskinesia in Parkinson's disease.
continuous monitoring capabilities to detect and quantify the severity of levodopa-induced
dyskinesia in Parkinson's disease.
Inclusion Criteria:
- Diagnosis of idiopathic Parkinson's disease
- Clinical history of levodopa-induced dyskinesia
- 21 Years of age or older
- Stage 2 - 4 OFF-medication on the Hoehn and Yahr scale
Exclusion Criteria:
- Dementia (determined by a neuropsychological assessment)
- Severe tremor unaffected by levodopa
We found this trial at
2
sites
Univ of Rochester Medical Center One of the nation's top academic medical centers, the University...
Click here to add this to my saved trials
Click here to add this to my saved trials